Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Geron Initiates Clinical Trial Of GRN163L In Combination With Paclitaxel And Bevacizumab In Patients With Breast Cancer
http://www.medicalnewstoday.com/articles/117733.php
Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer.
----------------------------------------------
** CANCER / ONCOLOGY News **
Statement From The American Institute For Cancer Research (AICR) Clarifying The Processed Meat-Cancer Link
http://www.medicalnewstoday.com/articles/117843.php
The American Institute for Cancer Research finds itself and its landmark expert report, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, caught in the middle of a furious PR battle between two conflicting interest groups.
New, Discrete-Angle Radiation Delivery Mode Extends Hi·Art(R) System Capabilities - Faster Planning And Treatment For Wide Range Of Cancer Cases
http://www.medicalnewstoday.com/articles/117839.php
<i>TomoTherapy</i> Incorporated (NASDAQ: TOMO) announced that it will introduce the <i>TomoDirect</i>™ discrete-angle delivery mode1 for the <i>TomoTherapy</i>® Hi·Art® treatment system at two upcoming radiation oncology conferences.
New Initiative Gives Cancer Physics A Boost - Queensland University Of Technology, Australia
http://www.medicalnewstoday.com/articles/117813.php
A health initiative spearheaded by QUT has received $800,000 from Queensland Health, allowing the university to attempt to raise the profile and increase the recognition of the field of cancer physics in the state.
Tumor Markers For Urothelial Carcinoma
http://www.medicalnewstoday.com/articles/117788.php
UroToday.com - Despite continued downward trends of smoking incidence in the United States over the last decade, the incidence of bladder cancer continues to rise with an estimated 68,800 new cases expected to be diagnosed in 2008.
Kayaking Prostate Cancer Survivor To Finish 1,700 Mile Paddle In NYC
http://www.medicalnewstoday.com/articles/117738.php
While Olympic athletes will begin vying for champion status this weekend in Beijing, Skip Ciccarelli, a 60-year-old survivor of prostate cancer, will complete his own Olympian effort. When he paddles up to New York's Pier 66 at noon on Saturday, he will be completing a 1,700 mile, 54-day kayak trek to raise awareness for prostate cancer--one of the most prevalent forms of cancer, second only to melanomas.
New Drug Development In Bladder Cancer: Understanding Biology To Develop Future Leads
http://www.medicalnewstoday.com/articles/117602.php
UroToday.com - Chemotherapy is effective in both locally advanced and metastatic bladder cancer. Two randomized trials have demonstrated that preoperative administration of Methotrexate, Vinblastine, Adriamycin, Cisplatin (MVAC) or Cisplatin, Methotrexte,Vinblastine (CMV) improve survival in patients with muscle invasive transitional cell carcinoma of the bladder.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Widen National Immunisation Register, Says Australian Medical Association
http://www.medicalnewstoday.com/articles/117832.php
AMA President, Dr Rosanna Capolingua, welcomed the announcement of a new national register of human papilloma virus vaccinations. But Dr Capolingua said the $23.5 million in Federal funding earmarked for the project could be used to develop and implement a whole-of-life immunisation register.
----------------------------------------------
** COLORECTAL CANCER News **
Grants To Fund Initiatives That Seek To Increase Colorectal Cancer Screenings, Reduce Health Disparities Among Immigrants
http://www.medicalnewstoday.com/articles/117876.php
Summaries of two grants that seek to reduce racial disparities appear below.<BR><ul><li class="AdvisoryBullet">Arkansas: NIH's <a href="http://ncmhd.nih.gov/" target="_new">National Center on Minority Health and Health Disparities</a> has awarded the <a href="http://www.
EXACT Sciences Announces Next Generation Stool-Based DNA Technology Study Results Of 92% For Colorectal Cancer Detection
http://www.medicalnewstoday.com/articles/117810.php
EXACT Sciences Corporation (NASDAQ: EXAS) announced the published results of a study in which stool and blood plasma were assessed, in a head-to-head comparison, for the detection of colorectal cancer (CRC).
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
1 In 5 Young Men Has Had Recent Prostate Cancer Test
http://www.medicalnewstoday.com/articles/117834.php
A new analysis finds that one in five men in their 40s has had a prostate specific antigen (PSA) test within the previous year and that young black men are more likely than young white men to have undergone the test.
Kayaking Prostate Cancer Survivor To Finish 1,700 Mile Paddle In NYC
http://www.medicalnewstoday.com/articles/117738.php
While Olympic athletes will begin vying for champion status this weekend in Beijing, Skip Ciccarelli, a 60-year-old survivor of prostate cancer, will complete his own Olympian effort. When he paddles up to New York's Pier 66 at noon on Saturday, he will be completing a 1,700 mile, 54-day kayak trek to raise awareness for prostate cancer--one of the most prevalent forms of cancer, second only to melanomas.
New Prostate Cancer Test Is Ready For Commercialization Following Successful Completion Of Final Clinical Trials
http://www.medicalnewstoday.com/articles/117736.php
Health Discovery Corporation ("HDC") (OTCBB: HDVY) announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed it's Phase III double-blind clinical trial and is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer.
Options In Prostate Cancer Surgery: Perineal Prostatectomy In The Age Of Minimally Invasive Surgery
http://www.medicalnewstoday.com/articles/117604.php
UroToday.com - In the age of minimally invasive surgery, laparoscopic and robotic assisted laparoscopic prostatectomy has been associated with a substantial increase in operative costs without a significant improvement in outcomes to date.
Medical Management Of Benign Prostatic Hyperplasia (BPH)/Lower Urinary Tract Symptoms (LUTS)
http://www.medicalnewstoday.com/articles/117600.php
UroToday.com - Benign Prostatic Hyperplasia (BPH) is the most common benign tumor in the aging male. The Symptoms associated with BPH, termed LUTS can be bothersome enough to significantly impact the life of men and their families.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment